No, you do not have to be clinically obese to be a candidate for GLP-1 medications like semaglutide or tirzepatide
Semaglutide is a member of a class of medications known as GLP-1 RAs, which stands for Glucagon-Like Peptide-1 Receptor Agonists. We know that looks and sounds like a mouthful, but these prescription drugs are uniquely designed for weight loss, management of type 2 diabetes, and reducing the risk of conditions like chronic kidney disease among certain populations
For instance, GHK-Cu combined with LED irradiation upregulates cell viability, bFGF, and collagen production more than either alone
(16) Clearly other contributing factors are at play, and some of the commonly reported ones specific to Graves disease are infections, stress, an excess of iodine , food intolerances ( gluten in particular), tobacco use, and the use of certain drugs (interferon-alfa, amiodarone, and CD52 mAbs)